Takara Bio Inc.
4974.T · JPX
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | ¥9,528 | ¥9,266 | ¥15,757 | ¥9,524 |
| % Growth | 2.8% | -41.2% | 65.4% | – |
| Cost of Goods Sold | ¥3,968 | ¥4,262 | ¥6,060 | ¥5,599 |
| Gross Profit | ¥5,560 | ¥5,004 | ¥9,697 | ¥3,925 |
| % Margin | 58.4% | 54% | 61.5% | 41.2% |
| R&D Expenses | ¥1,710 | ¥1,787 | ¥1,779 | ¥1,637 |
| G&A Expenses | ¥0 | ¥0 | ¥0 | ¥0 |
| SG&A Expenses | ¥4,262 | ¥4,820 | ¥4,182 | ¥4,192 |
| Sales & Mktg Exp. | ¥0 | ¥0 | ¥0 | ¥0 |
| Other Operating Expenses | ¥135 | ¥193 | ¥0 | -¥14 |
| Operating Expenses | ¥6,107 | ¥6,800 | ¥5,961 | ¥5,815 |
| Operating Income | -¥547 | -¥1,796 | ¥3,736 | -¥1,890 |
| % Margin | -5.7% | -19.4% | 23.7% | -19.8% |
| Other Income/Exp. Net | -¥3,994 | ¥14 | -¥355 | ¥79 |
| Pre-Tax Income | -¥4,541 | -¥1,782 | ¥3,381 | -¥1,811 |
| Tax Expense | ¥855 | -¥289 | ¥947 | ¥67 |
| Net Income | -¥5,401 | -¥1,510 | ¥2,420 | -¥1,891 |
| % Margin | -56.7% | -16.3% | 15.4% | -19.9% |
| EPS | -44.84 | -12.55 | 20.09 | -15.7 |
| % Growth | -257.3% | -162.5% | 228% | – |
| EPS Diluted | -44.84 | -12.55 | 20.09 | -15.7 |
| Weighted Avg Shares Out | 120 | 120 | 120 | 120 |
| Weighted Avg Shares Out Dil | 120 | 120 | 120 | 120 |
| Supplemental Information | – | – | – | – |
| Interest Income | ¥42 | ¥50 | ¥80 | ¥71 |
| Interest Expense | ¥126 | ¥117 | ¥5 | ¥5 |
| Depreciation & Amortization | ¥1,336 | ¥1,360 | ¥1,104 | ¥1,345 |
| EBITDA | -¥3,078 | -¥305 | ¥4,492 | -¥570 |
| % Margin | -32.3% | -3.3% | 28.5% | -6% |